A. Santora

956 total citations
8 papers, 564 citations indexed

About

A. Santora is a scholar working on Oncology, Orthopedics and Sports Medicine and Molecular Biology. According to data from OpenAlex, A. Santora has authored 8 papers receiving a total of 564 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 8 papers in Orthopedics and Sports Medicine and 1 paper in Molecular Biology. Recurrent topics in A. Santora's work include Bone health and osteoporosis research (8 papers), Bone health and treatments (8 papers) and Bone and Joint Diseases (6 papers). A. Santora is often cited by papers focused on Bone health and osteoporosis research (8 papers), Bone health and treatments (8 papers) and Bone and Joint Diseases (6 papers). A. Santora collaborates with scholars based in United States, Japan and France. A. Santora's co-authors include Douglas C. Bauer, Marc C. Hochberg, Dennis M. Black, Pierre Delmas, Susan K. Ewing, Patrick Garnero, Dieter Felsenberg, S. Adámi, Robert R. Recker and Douglas P. Kiel and has published in prestigious journals such as Journal of Bone and Mineral Research, Osteoporosis International and JAMA Internal Medicine.

In The Last Decade

A. Santora

8 papers receiving 533 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
A. Santora United States 4 501 447 222 57 36 8 564
A Pinchera Japan 3 480 1.0× 431 1.0× 193 0.9× 50 0.9× 37 1.0× 5 551
G. P. Dalsky United States 3 456 0.9× 324 0.7× 187 0.8× 112 2.0× 51 1.4× 4 533
B. Clemmesen Denmark 7 352 0.7× 275 0.6× 176 0.8× 32 0.6× 50 1.4× 8 413
Gérald Rajzbaum France 11 284 0.6× 172 0.4× 100 0.5× 117 2.1× 50 1.4× 17 361
Kousei Yoh Japan 11 132 0.3× 145 0.3× 89 0.4× 90 1.6× 23 0.6× 22 331
Katie Moss United Kingdom 4 233 0.5× 71 0.2× 90 0.4× 114 2.0× 33 0.9× 8 339
Guillermo Martínez Diaz‐Guerra Spain 10 128 0.3× 101 0.2× 48 0.2× 65 1.1× 36 1.0× 52 310
E Shane United States 4 193 0.4× 211 0.5× 67 0.3× 36 0.6× 40 1.1× 8 319
Miguel Quesada‐Charneco Spain 8 79 0.2× 55 0.1× 35 0.2× 66 1.2× 75 2.1× 18 283
Jean-Pierre Rivory France 4 51 0.1× 55 0.1× 61 0.3× 32 0.6× 16 0.4× 5 194

Countries citing papers authored by A. Santora

Since Specialization
Citations

This map shows the geographic impact of A. Santora's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by A. Santora with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites A. Santora more than expected).

Fields of papers citing papers by A. Santora

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by A. Santora. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by A. Santora. The network helps show where A. Santora may publish in the future.

Co-authorship network of co-authors of A. Santora

This figure shows the co-authorship network connecting the top 25 collaborators of A. Santora. A scholar is included among the top collaborators of A. Santora based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with A. Santora. A. Santora is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Bauer, Douglas C., Ann V. Schwartz, Lisa Palermo, et al.. (2014). Fracture Prediction After Discontinuation of 4 to 5 Years of Alendronate Therapy. JAMA Internal Medicine. 174(7). 1126–1126. 98 indexed citations
2.
Nakamura, Toshitaka, Masataka Shiraki, Masao Fukunaga, et al.. (2013). Effect of the cathepsin K inhibitor odanacatib administered once weekly on bone mineral density in Japanese patients with osteoporosis—a double-blind, randomized, dose-finding study. Osteoporosis International. 25(1). 367–376. 33 indexed citations
3.
Bauer, Douglas C., Patrick Garnero, Marc C. Hochberg, et al.. (2006). Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial. Journal of Bone and Mineral Research. 21(2). 292–299. 129 indexed citations
4.
Hosking, D., S. Adámi, Dieter Felsenberg, et al.. (2003). Once weekly alendronate produces a greater increase in bone mineral density than daily risedronate. Open Repository and Bibliography (University of Liège). 1 indexed citations
5.
Hosking, D., S. Adámi, Dieter Felsenberg, et al.. (2002). Once weekly alendronate produces a greater decrease in bone resorption than does daily risedronate. Open Repository and Bibliography (University of Liège). 1 indexed citations
6.
Schnitzer, Thomas J., Henry G. Bone, Gaetano Crepaldi, et al.. (2000). Therapeutic equivalence of alendronate 70 mg onceweekly and alendronate 10 mg daily in the treatment of osteoporosis. Aging Clinical and Experimental Research. 12(1). 1–12. 300 indexed citations
7.
Freedholm, Debra, Ronald Emkey, Steven D. Averbuch, et al.. (1996). Safety and tolerability of oral alendronate in the treatment of postmenopausal osteoporosis. Osteoporosis International. 6(S1). 261–261. 1 indexed citations
8.
Harris, Steven T., D. Hosking, S. Adámi, et al.. (1996). Treatment with alendronate prevents fractures in women with postmenopausal osteoporosis. Osteoporosis International. 6(S1). 261–261. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026